期刊文献+

虚拟组织学血管内超声的研究现状和展望 被引量:1

Current Status and Future Perspectives of Virtual Histology Intravascular Ultrasound*
下载PDF
导出
摘要 冠状动脉斑块的形态和组成反映了动脉粥样硬化的发展进程。病理研究将斑块分为稳定性斑块和不稳定性斑块,后者以大的脂质核心覆盖薄纤维帽为特征,是斑块破裂继发血栓形成导致急性冠状动脉综合征,或内膜增生致介入术后再狭窄的重要原因之一。虚拟组织学血管内超声能够有效地在体评价斑块的组成和性质。本综述主要介绍虚拟组织学血管内超声在心血管疾病尤其是介入心脏病学领域的研究进展。 Coronary arterial plaque morphology and composition indicate the progress of atherosclerosis.According to the pathological studies,coronary plaque can be divided into two groups—stable plaque without progression of stenosis and unstable plaque with progression of stenosis followed by acute coronary syndrome.The features of the latter are the presence of a large lipid core with a thin fibrous cap,which causes plaque rupture and/or thrombus followed by rapid progression,or intimal hyperplasia,which causes a gradual progressive condition,such as restenosis after percutaneous coronary intervention.Virtual histology intravascular ultrasound(VH-IVUS) is used to assess in vivo the characteristics of coronary plaque.The present article focuses on the progress of VH-IVUS in relation to its use in identifying atherosclerosis.
出处 《心血管病学进展》 CAS 2010年第6期788-790,共3页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(项目批准号:81000655)资助课题
关键词 虚拟组织学 血管内超声 介入心脏病学 virtual histology intravascular ultrasound atherosclerosis
  • 相关文献

参考文献1

二级参考文献22

  • 1Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504. 被引量:1
  • 2LaRosa JC, Grundy SM, Waters DD, et al; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435. 被引量:1
  • 3Pedersen TR, Faergeman O, Kastelein J J, et al; Incremental Decrease in End Points Through Aggressive Lipid Lowedng (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study:a randomized controlled trial. JAMA. 2005;294:2437-2445. 被引量:1
  • 4Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines. J Am Coll Cardiol. 2004;44:720-732. 被引量:1
  • 5Blankenhom DH, Azen SP, Kramsch DM, et al;MARS Research Group. Coronary angiographic changes with Iovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med.1993;119:969-976. 被引量:1
  • 6Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed be serial quantitaUve arteriography: the Canadian Coronary Atherosclerosis Intervention Trial(CCAIT). Circulation. 1994;89:959-968. 被引量:1
  • 7Jukema JW, Bruschke AV, van Boven A J, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528-2540. 被引量:1
  • 8Pitt B, Mancini GB, Ellis SG, Rosrnan HS, Park J-S,McGovem ME. Pravastatin limitaUon of atherosclerosis in the coronary arteries (PLAC Ⅰ): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol. 1995;26:1133-1139. 被引量:1
  • 9Brown G, Albers J J, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipidlowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298. 被引量:1
  • 10MAAS Study Group. Effect of simvastatin on coronary atheroma: the Multicentre Anti-atheroma Study( MAAS). Lancet. 1994;344:633 -638. 被引量:1

共引文献346

同被引文献8

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部